Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Improvements of Distribution Practices Essential for Pricing System Reform: Mr Nagano
June 30, 2008
- Multiparty Group of Diet Members to Discuss Increases in Tobacco Tax
June 30, 2008
- REGULATORY NEWS IN BRIEF
June 30, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 30, 2008
- RNAi Drugs Development Race Heats Up with Entry of Kyowa Hakko
June 30, 2008
- Kyowa Hakko Licenses RNAi Drug for RSV Infection from Alnylam
June 30, 2008
- Annual Meeting of Japanese Society of Chemotherapy
June 30, 2008
- Okayama Univ. to Lead Gene Therapy Research for Prostate Cancer in Asians
June 30, 2008
- R&D NEWS IN BRIEF
June 30, 2008
- Abbott Vascular Applies for XIENCE V
June 30, 2008
- Abbott Japan to Increase Pharma Group Sales to US$1 Bil. within 2 Years
June 30, 2008
- Terumo Acquires Clinical Supply from Eisai
June 30, 2008
- SELF-MEDICATION NEWS IN BRIEF
June 30, 2008
- Taiyo Leads Industry by Production Capacity and Prices: Mr Aratani
June 30, 2008
- NEW PRODUCTS
June 30, 2008
- 29.4% of Prescriptions Substituted Resulting in Savings of \420 Mil. in May: Nihon Chouzai
June 30, 2008
- Record-High 81 Applications Approved in FY2007
June 23, 2008
- REGULATORY NEWS IN BRIEF
June 23, 2008
- Nippon Shinyaku to Include RNA Drug Candidates in Its R&D Pipeline within 2 Years
June 23, 2008
- AnGes MG to Develop Gene Therapy for Mucopolysaccharidosis VI
June 23, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…